A Mobile App (Joint Effort) to Support Cannabis Use Self-Management and Reinforce the Use of Protective Behavioral Strategies: Development Process and Usability Testing
Côté J, Auger P, Chicoine G, Cheng J, Cossette S, Fontaine G, Genest C, Lal S, Lapierre J, Pagé MG, Maheu-Cadotte MA, Rouleau G, Vinette B, Jutras-Aswad D., JMIR Form Res. 2025
Overall and substance use-specific healthcare utilization among individuals with and without criminal justice involvement in Ontario, Canada
Russell, C., Yakubovich, A., O’Campo, P., Qu, K., Pluptre, L., Kouyoumdjian, F., Matheson, F. I., Int J Prison Health
Commentary on Coelho et al.: Ecological momentary assessments may be key to the future of cannabis studies
Chester L, Hebert FO, Jutras-Aswad D., Addiction. 2025
Cannabis legalization: a call for the integration of main health and crime indicator domains towards comprehensive policy impact assessments
Fischer B, Robinson T, Jutras-Aswad D., J Public Health Policy. 2025
Use of Buprenorphine/Naloxone in an Adult with Cystic Fibrosis
Mihic T, Fairbairn N, Nolan S, Dagenais R, Quon BS, Socias ME. Can J Hosp Pharm. 2025
Novel adulterants in unregulated opioids and their associations with adverse events
Tobias S, Angelucci J, Wood E, Buxton JA, Ti L., Can J Public Health. 2025
Responding to drug-related harm among South Asian populations in Canada
Mirza, N., Singh, M. & Hyshka, E., Can J Public Health
Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia’s drug decriminalization policy: Insights from a provincial survey
Russell,C., Law, J., Hodgson, K., Mackinnon, L., Shahin, R., Crichlow, F., Patenaude, S., Imtiaz, S., Rhem, J., Ali, F., Canadian Journal of Public Health
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis
Ti L, Mihic T, Beauchesne A, Grant C, Frank I, Haji N, Legal M, Shalansky S, Nolan S., Addict Sci Clin Pract. 2025
A protocol for high-dose lisdexamfetamine and contingency management, alone or in combination, for the treatment of methamphetamine use disorder: The ASCME study
Bach P, Le Foll B, Davidson S, de Kiewit A, Bakouni H, Poulin G, Ghosh M, Jutras-Aswad D., Contemp Clin Trials. 2025
